This is a service of EIN News a digital news provider
Tuesday February 9, 2010
Pharmaceutical Industry Today
Sign up for a free trial
Register Now
Member center Log In
Peramivir News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about pharmaceuticals.
FORMATS: RSS | EMAIL

Latest Peramivir News

Sort by: relevance (24 hours) relevance date
  • NexBio Granted United States Patent Covering DAS181 (Fludase) and its Use for Prevention and Treatment of Influenza and Parainfluenza 8 Feb 2010 19:35 GMT
    ... (Fludase) and its Use for Prevention and Treatment of Influenza and Parainfluenza SAN DIEGO, Calif., ... such compositions. DAS181 is a broad spectrum drug candidate in Phase II human clinical development, ... other antivirals such as Tamiflu®, Relenza® and peramivir," Dr. Wurtman added. The '448 patent is ...

  • Daiichi Sankyo Subsidiary Submits NDA For SUN Y7017 In Japan 8 Feb 2010 12:54 GMT
    ... with Hisamitsu Pharmaceutical for the cancer pain drug, KW-2246 (Orexo’ ... BioCryst Pharmaceuticals (BioCryst) has ... partner, Shionogi has launched Rapiacta, intravenous (iv) Peramivir anti-viral, to treat patients with influenza ... ... 60 doses (Budesonide/Formoterol fumarate dihydrate), for the treatment ... Shionogi & Co (Shionogi) has received ...

  • NexBio Granted United States Patent Covering DAS181 (Fludase(R) *) and its Use for Prevention and Tr 8 Feb 2010 17:10 GMT
    ... *) and its Use for Prevention and Treatment of Influenza and Parainfluenza NexBio Granted United ... such compositions. DAS181 is a broad spectrum drug candidate in Phase II human clinical development, ... other antivirals such as Tamiflu((R)), Relenza((R)) and peramivir," Dr. Wurtman added. The '448 patent is ...

  • Auxilium says FDA approved hand drug Xiaflex 3 Feb 2010 15:36 GMT
    ... Auxilium says FDA approved hand drug Xiaflex The Food and Drug Administration says ... telavancin, was approved in September as a treatment for complicated skin infections. Theravance and its ... partner will start selling the flu drug peramivir in Japan under the name Rapiacta. Shionogi ...

  • BioCryst Pharmaceuticals' 4th - quarter profit rises 50 percent on emergency flu drug sales 4 Feb 2010 18:20 GMT
    ... 50 percent on emergency sales of flu treatments, topping Wall Street forecasts. The company earned ... million. BioCryst is developing the flu treatment peramivir with funding from the Department of Health ... are too sick to take an oral drug. In October, the department authorized emergency use ...

  • BioCryst Pharmaceuticals reports higher profit 4 Feb 2010 18:24 GMT
    ... goal of building an enduring and successful biopharmaceutical company," CEO said in a statement. Fourth-quarter ... a U.S. government order for the flu drug and a milestone payment from a partner. The flu ... flu drug is being marketed in Japan. "Peramivir has delivered the first marketing authorization and ...

  • BioCryst Q4 results top Street on flu drug sales 4 Feb 2010 14:03 GMT
    ... pre-market trade Feb 4 (Reuters) - BioCryst Pharmaceuticals Inc ( ) reported fourth-quarter results that ... increase in sales of its key influenza drug, sending its shares up as much as 10 ... of 10,000 courses of BioCryst's intravenous drug peramivir from the Department of Health and Human ...

  • Daiichi Sankyo: new influenza drug may boost flagging Japanese market 3 Feb 2010 15:04 GMT
    ... Tamiflu and GlaxoSmithKline's Relenza (zanamivir), the only efficacious ... GlaxoSmithKline's Relenza (zanamivir), the only efficacious influenza drugs available until the recent launch of Rapiacta (peramivir; Shionogi), will soon have to face a ...

  • BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 4 Feb 2010 12:21 GMT
    ... announced two new partners to exclusively represent peramivir for stockpiling opportunities in their territories: Merck ... Phase 2 study for forodesine in the treatment of cutaneous T-cell lymphoma (CTCL) achieved its ... T-cell lymphoma (CTCL). Utilizing crystallography and structure-based drug design, BioCryst continues to discover additional compounds ...

  • BioCryst profits jump 50 percent 4 Feb 2010 18:36 GMT
    ... and Exchange Commission filings show. The Birmingham-based biotech firm reported $15.1 million in net income ... 10,000 courses of its lead experimental flu drug Peramivir with a value of $22.5 million under ...

  • Daiichi Sankyo Seeks Japanese Approval For Influenza Drug 1 Feb 2010 09:34 GMT
    ... of the company's HuCAL Platinum technology in drug discovery. In Apri ... BioCryst Pharmaceuticals (BioCryst) ... partner, Shionogi has launched Rapiacta, intravenous (iv) Peramivir anti-viral, to treat patients with influenza ... ... combination tablets, LD and HD, for the treatment of hypertension. ... Perseid Therapeutics (Perseid) has ...

  • BioCryst To Present At 12th Annual BIO CEO & Investor Conference 1 Feb 2010 22:30 GMT
    ... and updates regarding its clinical programs for peramivir, forodesine and BCX4208 at the 12th Annual ... on the BioCryst Web site at BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule pharmaceuticals ... lymphoma (CTCL). Â Utilizing crystallography and structure-based drug design, BioCryst continues to discover additional compounds and ...


1 - 15 / 38      NEXT >>>

Powered by Newsfeed Maker
NOT SATISFIED WITH THIS PERAMIVIR NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
 

send press release
EIN PRESSWIRE

Press Release Distribution Service
see all pharmaceuticals press releases »see all press releases »

list your company
EINDIRECTORY

add listing
EINEVENTS

get free trial
EINNEWS PUBLICATIONS

FORMATS: RSS

EIN News Columnists

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Pharmaceutical Companies News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

FDA News

MORE ARTICLES >>>

Take This Poll

Will the U.S. pass a health care bill by the end of June 2010? (Feb. 5, 2010)



 
FORMATS: RSS | EMAIL

Clinical Trials News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Drug News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Generic Drug News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Heart Drug News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Painkiller News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Cancer Drug News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Cholesterol Drug News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Diabetes Drug News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Antibiotics News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

HIV Drug News

MORE ARTICLES >>>

Pharmaceutical Industry Today

Drugs & Pharmaceuticals News Sections
Miscellaneous News Sections
Pharmaceuticals News by Region
Pharmaceuticals News by Country
Pharmaceuticals News by U.S. State

BUSINESS PROMOTION SERVICES

EIN Advertising · Place banner ads on EIN News industry specific publications.

EIN Presswire · Upload press releases to the EIN network and have them submitted to leading journalists and decision-makers worldwide.

EIN Global Events · Reach industry-specific readers and promote events, conferences or exhibitions.

EIN Business Directory · Present company or service information on highly-visible, industry and geo-specific news pages.

ALL NEWS PUBLICATIONS

You are currently reading Pharmaceutical Industry Today, an EIN News publication.

EIN News provides breaking news coverage on the following topics:

Regional / Politics
Barack Obama
Central Europe
China
EU Politics
Hillary Clinton
International Development
Military
Russia
US Politics
World News
Automotive
Automotive
Electric Cars
Hybrid Cars
Trucks		 Energy
Biofuels
Electric Power
Energy
Ethanol
Geothermal Power
Nuclear Power
Oil & Gas
Power Plants
Renewable Energy
Solar Energy
Wind Energy
Health / Pharmaceuticals
Brain Cancer
Breast Cancer
H1N1
Health
Lung Cancer
Mesothelioma
Pharmaceuticals
Prostate Cancer		 Business / Finance
Banking
Conferences
Employment
FOREX Trading
Finance
Gold
International Trade
Investing
Marketing
Real Estate
Science / Technology
Biotechnology
Environment
Global Warming
IT
Nanotechnology
Semiconductors
Software
Technology		 Culture / Society / Lifestyle
Books
Consumer
Human Rights
Media
Movies
Music
Religion
Travel
Company Daily Reports
Airbus
BP Energy
Boeing
Coca-Cola
ConocoPhillips
Exxon Mobil
Gazprom
Pepsi-Cola
Shell Energy
Starbucks		 Industry
Agriculture
Airlines
Chemicals
Cosmetics
Mining
Mobile Phone
Patents & Trademarks
Shipping & Logistics
Textiles
Tobacco
Waste Management
Food / Beverages
Beverages
Fast Food
Food Industry
Food Safety
Organic Food
Seafood

NEWS SERVICES

News Publications · In-depth geopolitical and industry specific news coverage aggregated from 35,000 online outlets. Updated every 15 minutes.

News Alerts · Receive a free selection of the day's top stories hand picked by EIN News editors.

Newsfeed Maker · Integrate customized newsfeeds in any format covering all industry and geopolitical topics, updated every 15 minutes.

EIN Presswire · Upload press releases to the EIN network and have them submitted to journalists and decision-makers worldwide.

Inbox Robot · Customized newsletters delivered by e-mail. Search a news index monitoring thousands of trusted media sources.

COMPANY BACKGROUND

About EIN News · Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become the largest digital news provider in Europe.

Member List · See the partial member list and join a community of professionals from private industry, institutions, and governments that rely on EIN as a critical source for research, breaking news and media services.

EIN News © 1995 - 2010 IPD Group, Inc. All Rights Reserved. | User Agreement | Privacy Policy | Contact